Details
Product Name in the RMS: Dacepton 5 mg/ml solution for infusion
MR Number: AT/H/0364/002
Date of outcome: 21.01.2014
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Abridged Additional Strength/Form Generic Chemical Substance Prescription Only |
Active Substances |
apomorphine hydrochloride hemihydrate 5 mg/ml |
Form | Solution for infusion |
MA Holder in the RMS |
EVER Neuro Pharma GmbH Oberburgau 3 4866 Unterach, Austria |
RMS | Austria |
Date of last change | 18.12.2019 |
ATC-Code |
N04BC07 Apomorphine |
CMS Country | Domestic Product Name |
---|---|
Belgium | Dacepton |
Bulgaria | Dacepton |
Croatia | |
Czech Republic | Dacepton® 5mg/ml Infuzní roztok |
Denmark | |
Estonia | DACEPTON 5 MG/ML |
Finland | Dacepton 5 mg/ml infuusioneste, liuos |
France | |
Germany | Dacepton 5 mg/ml Injektions-/Infusionslösung |
Greece | DOPACEPTIN |
Hungary | DACEPTON 5 mg/ml oldatos infúzió |
Ireland | |
Italy | |
Latvia | Dacepton 5 mg/ml šķīdums infūzijām |
Lithuania | Dacepton 5mg/ml infuzinis tirpalas |
Luxembourg | |
Netherlands | Dacepton 5 mg/ml oplossing voor infusie |
Norway | Dacepton |
Poland | Dacepton |
Portugal | |
Romania | Dacepton® 5mg/ml Soluţie perfuzabilă |
Slovak Republic | |
Slovenia | |
Spain | |
Sweden | |
United Kingdom |
Documents | |
---|---|
PAR: | AT_H_0364_002_PAR.pdf (04.12.2019) |
FinalSPC: | AT_H_0364_002_FinalSPC.pdf (10.12.2018) |
FinalPL: | AT_H_0364_002_FinalPL.pdf (10.12.2018) |
FinalLabelling: | AT_H_0364_002_FinalLabelling.pdf (10.12.2018) |